Epigene Labs

📍 Paris, France🗓 Founded 2019👥 26 employees💰 Last funded Jul 2020
Biotechnology Research🌐 epigenelabs.com
Website LinkedIn
Epigene Labs is creating the intelligence-augmenting solution for precision oncology research and drug development. Designed by cancer scientists for cancer scientists, the company's mCUBE platform accelerates data-driven drug discovery, biomarker identification, and patient selection -- to bring better treatments to patients faster. Based in Paris and Boston, Epigene Labs was initially incubated at the Harvard Innovation Labs and launched in France with the support of prominent European investors. Epigene Labs has partnerships with world-class cancer research institutes and biopharmaceutical companies.
4
Total investors
4
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
3
Germany
1
Investor activity2019–2020 · investors recorded per year
2019220202
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Epigene Labs?
Epigene Labs has 4 investors on record on gritt.io, including 4 early-stage backers.
When did Epigene Labs last raise funding?
The most recent investment in Epigene Labs recorded on gritt.io was in July 2020.
When was Epigene Labs founded?
Epigene Labs was founded in 2019.
What industry is Epigene Labs in?
Epigene Labs operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Epigene Labs based?
Epigene Labs is headquartered in Paris, France.